selected scholarly activity
-
academic article
- Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐ VTE Cancer study. Journal of Thrombosis and Haemostasis. 17:1866-1874. 2019
- Follow‐up to comment on “Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta‐Analysis”. Journal of Thrombosis and Haemostasis. 17:1007-1009. 2019
- The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica. 104:1277-1287. 2019
- Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 17:645-656. 2019
- Extended treatment of venous thromboembolism: a systematic review and network meta-analysis. Heart British Heart Journal. 105:545-552. 2019
- Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis. Thrombosis Research. 176:79-84. 2019
- Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism. Thrombosis Research. 171:92-96. 2018
- Direct oral anticoagulants in patients with liver cirrhosis: A systematic review. Thrombosis Research. 170:102-108. 2018
- Reporting bias in imaging: higher accuracy is linked to faster publication. European Radiology. 28:3632-3639. 2018
- Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thrombosis and Haemostasis. 118:1439-1449. 2018
- A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. The Lancet Haematology. 5:e289-e298. 2018
- Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment. Journal of Thrombosis and Haemostasis. 16:1445-1448. 2018
- Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study. Thrombosis and Haemostasis. 118:1270-1278. 2018
- Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thrombosis Research. 166:54-59. 2018
- Sex‐specific performance of pre‐imaging diagnostic algorithms for pulmonary embolism. Journal of Thrombosis and Haemostasis. 16:858-865. 2018
- Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thrombosis Research. 163:41-46. 2018
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. New England Journal of Medicine. 378:615-624. 2018
- Genes associated with venous thromboembolism in colorectal cancer patients. Journal of Thrombosis and Haemostasis. 16:293-302. 2018
- Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients. Thrombosis and Haemostasis. 118:174-181. 2018
- Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism. Annals of Internal Medicine. 167:410-410. 2017
- Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica. 102:1494-1501. 2017
- Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials. European Respiratory Journal European Respiratory Journal, Supplement. 50:1701097-1701097. 2017
- Overinterpretation of Research Findings: Evidence of “Spin” in Systematic Reviews of Diagnostic Accuracy Studies. Clinical Chemistry. 63:1353-1362. 2017
- The diagnostic management of upper extremity deep vein thrombosis: A review of the literature. Thrombosis Research. 156:54-59. 2017
- D-dimer Interval Likelihood Ratios for Pulmonary Embolism. Academic Emergency Medicine. 24:832-837. 2017
- Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis. BMJ Open. 7:e015562-e015562. 2017
- Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores. Thrombosis Research. 152:52-60. 2017
- The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis. Journal of Thrombosis and Haemostasis. 15:678-684. 2017
- Is stand‐alone D‐dimer testing safe to rule out acute pulmonary embolism?. Journal of Thrombosis and Haemostasis. 15:323-328. 2017
- The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer. Thrombosis Research. 150:30-32. 2017
- Improving the diagnostic management of upper extremity deep vein thrombosis. Journal of Thrombosis and Haemostasis. 15:66-73. 2017
- Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability?. Thrombosis and Haemostasis. 117:1622-1629. 2017
- A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients. Thrombosis Research. 148:59-62. 2016
- Deep vein thrombosis and pulmonary embolism. The Lancet. 388:3060-3073. 2016
- Time to publication among completed diagnostic accuracy studies: associated with reported accuracy estimates. BMC Medical Research Methodology. 16:68. 2016
- Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots. Thrombosis Research. 147:46-51. 2016
- Wells Rule andd-Dimer Testing to Rule Out Pulmonary Embolism. Annals of Internal Medicine. 165:253-253. 2016
- Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. The Lancet Haematology. 3:e379-e387. 2016
- Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis. Journal of Thrombosis and Haemostasis. 14:973-981. 2016
- Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review. Thrombosis Research. 140:S81-S88. 2016
- PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis. Thrombosis Research. 140:S179-S179. 2016
- Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy. Drugs. 76:331-341. 2016
- Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open. 6:e010569-e010569. 2016
- Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2015:125-131. 2015
- The effect of trauma and patient related factors on radial head fractures and associated injuries in 440 patients. BMC Musculoskeletal Disorders. 16:135. 2015
- Whole-Arm Ultrasound for Suspected Upper-Extremity Deep Venous Thrombosis in Outpatients. JAMA Internal Medicine. 175:1871-1871. 2015
- Clinical Significance of Tissue Factor–Exposing Microparticles in Arterial and Venous Thrombosis. Seminars in Thrombosis and Hemostasis. 41:718-727. 2015
- Safety of anticoagulant treatment in cancer patients. Expert Opinion on Drug Safety. 14:1227-1236. 2015
- Edoxaban for treatment of venous thromboembolism in patients with cancer. Thrombosis and Haemostasis. 114:1268-1276. 2015
- Extracellular vesicles, tissue factor, cancer and thrombosis – discussion themes of the ISEV 2014 Educational Day. Journal of Extracellular Vesicles. 4:26901-26901. 2015
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 124:1968-1975. 2014
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.. Blood. 124:1968-1975. 2014
- Effects of Cancer on Platelets. Seminars in Oncology. 41:311-318. 2014
- Cancer-associated unsuspected pulmonary embolism. Thrombosis Research. 133:S172-S178. 2014
- New developments in parenteral anticoagulation for arterial and venous thromboembolism. Best Practice and Research in Clinical Haematology Bailliere's Clinical Haematology. 26:203-213. 2013
- Diagnosis and prognosis of acute hamstring injuries in athletes. Knee Surgery, Sports Traumatology, Arthroscopy. 21:500-509. 2013
- Impact of stereotactic large-core needle biopsy on diagnosis and surgical treatment of non-palpable breast cancer. European Journal of Surgical Oncology. 27:244-249. 2001
-
conference paper
- Can we use the Khorana risk score to predict venous thromboembolism in patients with cancer? A systematic review and meta-analysis. Thrombosis Research. S234-S234. 2018
- Clinical impact of bleeding in cancer-associated venous thromboembolism: results from the Hokusai VTE Cancer randomized trial. Thrombosis Research. S223-S223. 2018
- Efficacy and safety of edoxaban in clinically relevant subgroups: results from the Hokusai VTE Cancer randomized trial. Thrombosis Research. S194-S194. 2018
- Genes associated with venous thromboembolism in colorectal cancer patients. Thrombosis Research. S228-S229. 2018
- Risk scores for occult cancer in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study. Thrombosis Research. S224-S224. 2018
- Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study. Thrombosis Research. S193-S194. 2018
- Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients. Blood. 2611-2611. 2016
- Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis. Thrombosis Research. S179-S179. 2016
- Withholding anticoagulation after negative CTPA is safe in patients with a likely clinical probability of PE. European Heart Journal. 627-627. 2015
- Performance of a diagnostic strategy using a clinical decision rule and D-dimer testing to exclude upper extremity deep vein thrombosis in clinically important subgroups. Journal of Thrombosis and Haemostasis. 977-978. 2015
- Recurrent venous thromboembolism and mortality in cancer patients with upper extremity deep vein thrombosis. Journal of Thrombosis and Haemostasis. 207-207. 2015
- The current management strategies and clinical outcome of upper extremity deep vein thrombosis. Journal of Thrombosis and Haemostasis. 70-71. 2015
- The performance of the age-adjusted d-dimer threshold for suspected pulmonary embolism in relevant subgroups: an individual patient data meta-analysis of 7000 patients. Journal of Thrombosis and Haemostasis. 477-477. 2015
- Unsuspected pulmonary embolism in cancer patients: an international, ongoing, prospective, observational study. Journal of Thrombosis and Haemostasis. 545-546. 2015
- Withholding anticoagulation after normal CTPA is safe in patients with a high clinical probability of PE in the absence of a prior episode of VTE. Journal of Thrombosis and Haemostasis. 167-167. 2015
- A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer. Blood. 2014
- Unsuspected Pulmonary Embolism in Cancer Patients: A Multicenter, International, Prospective, Observational Study. Blood. 2014
- External validation of current VTE risk prediction scores for patients with solid cancer in an ongoing prospective multicenter cohort study. Thrombosis Research. S208-S209. 2014